News | Endovascular Aortic Repair | April 05, 2017

New Study Confirms More Unfavorable Outcomes for Women Than Men After AAA Repair

Evidence suggests Aortic Size Index (ASI) may be a better indicator for treatment for female patients and reduces gender differences in outcomes

abdominal aortic aneurysm, AAA, gender differences, women vs. men, endovascular repair, Journal of Vascular Surgery study

April 5, 2017 — Following repair of abdominal aortic aneurysms (AAA), women appear to have more unfavorable outcomes than men in terms of mortality and morbidity.

Aortic aneurysm rupture remains a significant cause for morbidity and mortality. With increasing awareness, as well as continued screening programs, the medical community can limit the impact of this vascular disease.

Current indications for surgical repair include aneurysm diameter greater than 5.5cm (in men), rapid growth, symptoms and rupture. Because women tend to be smaller in stature, repair at smaller diameters are often recommended. Women are less likely to develop AAA, but when they do, the aneurysm tends to grow faster and ruptures sooner than in men. Once treated, evidence suggests women have worse outcomes than men following procedures to repair AAA.

 As reported in an article in the April edition of the Journal of Vascular Surgery, researchers from Harvard’s Beth Israel Deaconess Medical Center and Massachusetts General Hospital, led by vascular surgeon Marc Schermerhorn, M.D., performed a study examining gender differences in AAA repair. 

Reviewing data from 6,611 patients undergoing AAA repair registered in the National Surgical Quality Improvement Program database, this group confirmed previous work suggesting higher morbidity and mortality in women following repair, even after adjusting for age, aortic diameter and other medical conditions.

A possible explanation for this difference proposed by the authors is that women have smaller baseline aortic diameters given their overall smaller body size. The researchers re-analyzed the data using Aortic Size Index (ASI) instead of aortic diameter. This index divides aortic diameter by body surface area. 

In doing so, Schermerhorn noted that “Adjusting for ASI reduces these (gender) differences, suggesting that ASI may be a better indicator threshold for AAA repair for female patients.”

Using ASI as a key component of indicator threshold may prevent unnecessary procedures, significantly reduce risk and increase the chances of a more favorable outcome.

For more information: www.jvascsurg.org


Related Content

News | Cardiovascular Clinical Studies

May 6, 2026 — Image Analysis Group (IAG), a global imaging CRO headquartered in London, U.K., and HeartcoR Solutions ...

Home May 06, 2026
Home
News | Cardiovascular Clinical Studies

April 9, 2026 — Mount Sinai researchers have created an analytic tool using machine learning that can predict ...

Home April 14, 2026
Home
News | Cardiovascular Clinical Studies

April 13, 2026 —The American Heart Association (AHA) has granted Case Western Reserve University the Rapid Impact ...

Home April 13, 2026
Home
News | Cardiovascular Clinical Studies

April 2, 2026 — Iterative Health and US Heart & Vascular (USHV) have announced a strategic partnership to advance ...

Home April 02, 2026
Home
News | Cardiovascular Clinical Studies

March 4, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced Late-Breaking clinical ...

Home March 04, 2026
Home
News | Cardiovascular Clinical Studies

Feb. 9, 2026 — HTA and MedAxiom have opened applications for the 2026 HeartX program, a cardiovascular-focused ...

Home February 18, 2026
Home
News | Cardiovascular Clinical Studies

Jan. 5, 2026 — Medera Inc., a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by ...

Home January 05, 2026
Home
News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
Subscribe Now